Most Read Articles

Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

Maria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, Natalia B Amaral, Pamella Indira Menezes, Saulo Musse Dib, Samara Libich Gigante, Maira N Benatti, Uebe C Rezek, Laerte L Emrich-Filho, Betania A A Sousa, Sergio C L Almeida, Rodrigo Luppino Assad, Flavio P Veras, Ayda Schneider, Tamara S Rodrigues, Luiz O S Leiria, Larissa D Cunha, Jose C Alves-Filho, Thiago M Cunha, Eurico Arruda, Carlos H Miranda, Antonio Pazin-Filho, Maria Auxiliadora-Martins, Marcos C Borges, Benedito A L Fonseca, Valdes R Bollela, Cristina M Del-Ben, Fernando Q Cunha, Dario S Zamboni, Rodrigo C Santana, Fernando C Vilar, Paulo Louzada-Junior, Rene D R Oliveira

10.1136/rmdopen-2020-001455

February 4, 2021

Reactive arthritis after COVID-19 infection

Keisuke Ono, Mitsumasa Kishimoto, Teppei Shimasaki, Hiroko Uchida, Daisuke Kurai, Gautam A Deshpande, Yoshinori Komagata, Shinya Kaname

10.1136/rmdopen-2020-001350

August 6, 2020

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)

Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, Pedro Plazuelo-Ramos, Dale Webb, Clare Jacklin, Shantel Irwin, Laurent Grange, Souzi Makri, Elsa Frazão Mateus, Serena Mingolla, Katy Antonopoulou, Sergio Sanz-Gómez, José Correa-Fernández, Loreto Carmona, Victoria Navarro-Compán

10.1136/rmdopen-2020-001546

April 7, 2021